How is the Sarepta Therapeutics Inc today?

The Sarepta Therapeutics Inc today is trading in the green, up by 8.74% at 79.97.

Sarepta Therapeutics Inc XNAS: SRPT

Sarepta Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Sarepta Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Sarepta Therapeutics Inc
Rating: 2.5896945
Author: Trendlyne DVM scores

Falling Comet

Download real time

79.97 6.43 (8.74%)

New 52W Low in past week

5.0M XNAS Volume

High volume+gain today

XNAS 19 Mar, 2025 5:30 PM (EDT)

Treatment Failure

Sarepta plunges on Tuesday as a patient treated with its gene therapy died from acute liver failure See details

High Financial Strength

77.8 / 100

Expensive Valuation

28.5 / 100

Technically Bearish

23.1 / 100

Falling Comet These stocks are with good financial quality. But, their bad valuation and technical aspects make the investor think before investing. View Similar Embed DVM

173

1Yr Price target upside is 117%

23 analysts

Sarepta Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sarepta Therapeutics Inc FAQ

How is Sarepta Therapeutics Inc today?

Sarepta Therapeutics Inc today is trading in the green, and is up by 8.74% at 79.97.

How has Sarepta Therapeutics Inc performed historically?

Sarepta Therapeutics Inc is currently trading up 8.74% on an intraday basis. In the past week the stock fell -20.59%. stock has been down -35.57% in the past quarter and fell -35.49% in the past year. You can view this in the overview section.